These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

438 related articles for article (PubMed ID: 23787278)

  • 41. HER2 Targeted Breast Cancer Therapy with Switchable "Off/On" Multifunctional "Smart" Magnetic Polymer Core-Shell Nanocomposites.
    Vivek R; Thangam R; Kumar SR; Rejeeth C; Kumar GS; Sivasubramanian S; Vincent S; Gopi D; Kannan S
    ACS Appl Mater Interfaces; 2016 Jan; 8(3):2262-79. PubMed ID: 26771508
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Synergistic effect of quercetin and pH-responsive DEAE-chitosan carriers as drug delivery system for breast cancer treatment.
    de Oliveira Pedro R; Goycoolea FM; Pereira S; Schmitt CC; Neumann MG
    Int J Biol Macromol; 2018 Jan; 106():579-586. PubMed ID: 28807690
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Polymeric nanoparticles of cholesterol-modified glycol chitosan for doxorubicin delivery: preparation and in-vitro and in-vivo characterization.
    Yu JM; Li YJ; Qiu LY; Jin Y
    J Pharm Pharmacol; 2009 Jun; 61(6):713-9. PubMed ID: 19505361
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Enhanced anti-tumor efficacy by co-delivery of doxorubicin and paclitaxel with amphiphilic methoxy PEG-PLGA copolymer nanoparticles.
    Wang H; Zhao Y; Wu Y; Hu YL; Nan K; Nie G; Chen H
    Biomaterials; 2011 Nov; 32(32):8281-90. PubMed ID: 21807411
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Application of quality-by-design approach to optimize diallyl disulfide-loaded solid lipid nanoparticles.
    Talluri SV; Kuppusamy G; Karri VV; Yamjala K; Wadhwani A; Madhunapantula SV; Pindiprolu SS
    Artif Cells Nanomed Biotechnol; 2017 May; 45(3):474-488. PubMed ID: 27112220
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Facile preparation of well-defined near-monodisperse chitosan/sodium alginate polyelectrolyte complex nanoparticles (CS/SAL NPs) via ionotropic gelification: a suitable technique for drug delivery systems.
    Liu P; Zhao X
    Biotechnol J; 2013 Jul; 8(7):847-54. PubMed ID: 23625874
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hyaluronic acid-coated chitosan nanoparticles as targeted-carrier of tamoxifen against MCF7 and TMX-resistant MCF7 cells.
    Nokhodi F; Nekoei M; Goodarzi MT
    J Mater Sci Mater Med; 2022 Feb; 33(2):24. PubMed ID: 35157166
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Preparation and characterization of rod-like chitosan-quinoline nanoparticles as pH-responsive nanocarriers for quercetin delivery.
    Rahimi S; Khoee S; Ghandi M
    Int J Biol Macromol; 2019 May; 128():279-289. PubMed ID: 30695722
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Chitosan-modified PLGA polymeric nanocarriers with better delivery potential for tamoxifen.
    Thakur CK; Thotakura N; Kumar R; Kumar P; Singh B; Chitkara D; Raza K
    Int J Biol Macromol; 2016 Dec; 93(Pt A):381-389. PubMed ID: 27586640
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Nanoparticles loaded with ferrocenyl tamoxifen derivatives for breast cancer treatment.
    Nguyen A; Marsaud V; Bouclier C; Top S; Vessieres A; Pigeon P; Gref R; Legrand P; Jaouen G; Renoir JM
    Int J Pharm; 2008 Jan; 347(1-2):128-35. PubMed ID: 17643877
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Chitosan/o-carboxymethyl chitosan nanoparticles for efficient and safe oral anticancer drug delivery: in vitro and in vivo evaluation.
    Feng C; Wang Z; Jiang C; Kong M; Zhou X; Li Y; Cheng X; Chen X
    Int J Pharm; 2013 Nov; 457(1):158-67. PubMed ID: 24029170
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hyaluronic acid-coated chitosan nanoparticles induce ROS-mediated tumor cell apoptosis and enhance antitumor efficiency by targeted drug delivery via CD44.
    Wang T; Hou J; Su C; Zhao L; Shi Y
    J Nanobiotechnology; 2017 Jan; 15(1):7. PubMed ID: 28068992
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Fabrication and study of curcumin loaded nanoparticles based on folate-chitosan for breast cancer therapy application.
    Esfandiarpour-Boroujeni S; Bagheri-Khoulenjani S; Mirzadeh H; Amanpour S
    Carbohydr Polym; 2017 Jul; 168():14-21. PubMed ID: 28457434
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Enhanced drug-loading and therapeutic efficacy of hydrotropic oligomer-conjugated glycol chitosan nanoparticles for tumor-targeted paclitaxel delivery.
    Koo H; Min KH; Lee SC; Park JH; Park K; Jeong SY; Choi K; Kwon IC; Kim K
    J Control Release; 2013 Dec; 172(3):823-31. PubMed ID: 24035978
    [TBL] [Abstract][Full Text] [Related]  

  • 55. In vitro antitumor activity of methotrexate via pH-sensitive chitosan nanoparticles.
    Nogueira DR; Tavano L; Mitjans M; Pérez L; Infante MR; Vinardell MP
    Biomaterials; 2013 Apr; 34(11):2758-72. PubMed ID: 23352041
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Doxorubicin-conjugated core-shell magnetite nanoparticles as dual-targeting carriers for anticancer drug delivery.
    Sadighian S; Rostamizadeh K; Hosseini-Monfared H; Hamidi M
    Colloids Surf B Biointerfaces; 2014 May; 117():406-13. PubMed ID: 24675279
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Smart nanovehicles based on pH-triggered disassembly of supramolecular peptide-amphiphiles for efficient intracellular drug delivery.
    Xu X; Li Y; Li H; Liu R; Sheng M; He B; Gu Z
    Small; 2014 Mar; 10(6):1133-40. PubMed ID: 24155260
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Delivery of curcumin by a pH-responsive chitosan mesoporous silica nanoparticles for cancer treatment.
    Ahmadi Nasab N; Hassani Kumleh H; Beygzadeh M; Teimourian S; Kazemzad M
    Artif Cells Nanomed Biotechnol; 2018 Feb; 46(1):75-81. PubMed ID: 28278578
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Chitosan magnetic nanoparticles for pH responsive Bortezomib release in cancer therapy.
    Unsoy G; Yalcin S; Khodadust R; Mutlu P; Onguru O; Gunduz U
    Biomed Pharmacother; 2014 Jun; 68(5):641-8. PubMed ID: 24880680
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Biocompatible fluorescent carbon nanoparticles as nanocarriers for targeted delivery of tamoxifen for regression of Breast carcinoma.
    Puvvada N; Shaik MAS; Samanta D; Shaw M; Mondal I; Basu R; Bhattacharya A; Pathak A
    Spectrochim Acta A Mol Biomol Spectrosc; 2024 Nov; 321():124721. PubMed ID: 38943755
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.